COMMUNIQUÉS West-GlobeNewswire

OncBioMune Returns Protocol to Scientific Review Committee Overseeing Phase 2 Prostate Cancer Clinical Trial

28/03/2018 - 15:10

BATON ROUGE, La., March 28, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Arcturus Therapeutics Issues Open Letter to Shareholders

28/03/2018 - 15:04

Details Former President and CEO Joseph E. Payne’s Poor Judgment, Failed Leadership and Deceit that Led to His Termination for Cause Cites Payne’s Self-Dealing and Blatant Disloyalty to Arcturus, its Shareholders and [...]

ATW Tech Announces a Contemplated Private Placement of $1.5 Million

28/03/2018 - 15:00

MONTREAL, March 28, 2018 (GLOBE NEWSWIRE) -- ATW Tech (“AtmanCo” or the “Company”) (TSX-V: ATW ) is proud to announce that it has entered into an agreement with the lead agent, Leede Jones Gable Inc. (the “Agent”), to [...]

ATW Tech annonce une proposition de placement privé de 1,5 million

28/03/2018 - 15:00

MONTREAL, 28 mars 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo » ou la « Société ») (TSX-V: ATW ) est fier d’annoncer aujourd’hui s’être entendu avec Leede Jones Gables inc. (l’ « Agent ») à titre d’agent principal pour [...]

Pacgen Announces New Management Structure and Reports on P113 Commercial Progress

28/03/2018 - 15:00

VANCOUVER, British Columbia, March 28, 2018 (GLOBE NEWSWIRE) -- Pacgen Life Science Corporation (“Pacgen” or the “Company”) (TSX-V: PBS ) is pleased to announce that its board of directors (the “Board”) has appointed a [...]

Western Maryland Health System Chooses Artifact Health’s Mobile Platform to Simplify and Automate the Physician Query Process

28/03/2018 - 15:00

BOULDER, Colo., March 28, 2018 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile platform that streamlines the physician query process, announced today that Western Maryland Health System [...]

Orion Biotechnology Canada Announces Partnership with Nanjing University

28/03/2018 - 15:00

OTTAWA, March 28, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd, a developer of novel medical treatments for chronic illness and life-threatening diseases, today announced a strategic partnership with the [...]

TOMI Environmental Solutions, Inc. to Hold Fourth Quarter 2017 Financial Results Conference Call on Monday, April 2, 2018

28/03/2018 - 15:00

BEVERLY HILLS, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) ), a global decontamination company that specializes in disinfection/decontamination sales and services [...]

Editas Medicine Names James C. Mullen as Chairman of the Board of Directors

28/03/2018 - 15:00

CAMBRIDGE, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced the appointment of James C. Mullen as Chairman of the Board of Directors, [...]

Progyny to Sponsor 2018’s National Infertility Awareness Week® and Night of Hope Which Supports RESOLVE: The National Infertility Association

28/03/2018 - 15:00

NEW YORK, March 28, 2018 (GLOBE NEWSWIRE) -- Progyny, the leading fertility benefits management company, announced today its sponsorship of National Infertility Awareness Week® (NIAW) from April 22 nd to April 28 th and [...]

Shire plc : Statement re Possible Offer

28/03/2018 - 14:31

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION 28 March 2018 Shire [...]

American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention

28/03/2018 - 14:30

ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today congratulates Robert R. Redfield, M.D., on his appointment as the [...]

Interpace Diagnostics Announces Agreement with Acupath Laboratories

28/03/2018 - 14:30

PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]

Xenon Pharmaceuticals Confirms Closing of Transaction with Teva and Announces Preferred Share Exchange Agreement with BVF Partners L.P.

28/03/2018 - 14:30

BURNABY, British Columbia, March 28, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical stage biopharmaceutical company, today reported the closing of the previously announced transaction [...]

Histogenics Corporation to Present at Upcoming Investor Conferences

28/03/2018 - 14:30

WALTHAM, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

28/03/2018 - 14:30

LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ), an emerging leader in the development and commercialization of innovative medical diagnostic products, announces the publication [...]

Paratek Pharmaceuticals to Present at the H.C. Wainwright Annual Global Life Sciences Conference

28/03/2018 - 14:00

BOSTON, March 28, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ) today announced that President, Chief Operating Officer and Chief Medical Officer, Evan Loh, MD will present at the upcoming H.C. [...]

Apricus Biosciences Announces Pricing of $3.55 Million Public Offering

28/03/2018 - 14:00

SAN DIEGO, March 28, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI ), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has priced a [...]

BioSig Announces Submission of FDA 510(k) Application for PURE EP System

28/03/2018 - 14:00

Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first [...]